BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Where will we be in 12 months time?, page-89

  1. 2,128 Posts.
    lightbulb Created with Sketch. 1508
    "that's incorrect BOT would have to submit ALL data for reevaluation you can't just ignore people that didn't follow or not submit it."

    Actually, you can. Because it is not a clinical trial in itself, BOT do not need to provide ALL data, just that which demonstrates patients understand how to use the drug.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.